OMDA — Omada Health Cashflow Statement
0.000.00%
- $1.08bn
- $885.99m
- $169.80m
- 37
- 29
- 81
- 47
Annual cashflow statement for Omada Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -72.5 | -67.5 | -47.1 |
| Depreciation | |||
| Non-Cash Items | 8.35 | 14.8 | 14.7 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -9.14 | -1.5 | -6.57 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -69 | -49.7 | -34.2 |
| Capital Expenditures | -2.72 | -2.92 | -3.86 |
| Purchase of Fixed Assets | |||
| Software Development Costs | |||
| Cash from Investing Activities | -2.72 | -2.92 | -3.86 |
| Financing Cash Flow Items | 0 | -0.734 | -4.54 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 16.3 | 0.179 | -1.21 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -55.4 | -52.5 | -39.3 |